Stable cell line development is services that cover most of the cell cultures. It is primarily used in research applications and selective diagnosis, the applications involved in stable cell line development covers recombinant protein and antibody production, functional studies, drug screening, gene editing, assay development, and many other platforms.
This report contains market size and forecasts of Stable Cell Line Development in Global, including the following market information:
Global Stable Cell Line Development Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Stable Cell Line Development market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Recombinant Cell Line Development Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Stable Cell Line Development include Genscript Biotech, Molecular Devices, Thermo Fisher Scientific, ProteoGenix, Sino Biological, OriGene Technologies, Fusion Antibodies, GeneCopoeia and BPS Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Stable Cell Line Development companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stable Cell Line Development Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Stable Cell Line Development Market Segment Percentages, by Type, 2021 (%)
Recombinant Cell Line Development
Continuous Cell Line Development
Primary Cell Line Development
Global Stable Cell Line Development Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Stable Cell Line Development Market Segment Percentages, by Application, 2021 (%)
Hospital
Research Laboratory
Others
Global Stable Cell Line Development Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Stable Cell Line Development Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stable Cell Line Development revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Stable Cell Line Development revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genscript Biotech
Molecular Devices
Thermo Fisher Scientific
ProteoGenix
Sino Biological
OriGene Technologies
Fusion Antibodies
GeneCopoeia
BPS Bioscience
Creative Biomart
InVivo BioTech
Creative Biolabs
Creative Biogene